9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9159B |
Disopyramide Screen, Blood |
9159SP |
Disopyramide Screen, Serum/Plasma |
9190B |
Ketoacidosis Screen, Postmortem, Blood (Forensic) |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9211B |
Mexiletine Screen, Blood |
9211SP |
Mexiletine Screen, Serum/Plasma |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9327B |
Propane, Blood |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |